JP7607939B2 - 喘息を治療するための方法 - Google Patents

喘息を治療するための方法 Download PDF

Info

Publication number
JP7607939B2
JP7607939B2 JP2021574818A JP2021574818A JP7607939B2 JP 7607939 B2 JP7607939 B2 JP 7607939B2 JP 2021574818 A JP2021574818 A JP 2021574818A JP 2021574818 A JP2021574818 A JP 2021574818A JP 7607939 B2 JP7607939 B2 JP 7607939B2
Authority
JP
Japan
Prior art keywords
asthma
dapanstril
airway
mice
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021574818A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022536932A5 (cg-RX-API-DMAC7.html
JP2022536932A (ja
Inventor
エー.ディナレロ チャールズ
マーチェッティ カルロ
Original Assignee
オラテック セラピューティクス, インコーポレイティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オラテック セラピューティクス, インコーポレイティド filed Critical オラテック セラピューティクス, インコーポレイティド
Publication of JP2022536932A publication Critical patent/JP2022536932A/ja
Publication of JP2022536932A5 publication Critical patent/JP2022536932A5/ja
Application granted granted Critical
Publication of JP7607939B2 publication Critical patent/JP7607939B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2021574818A 2019-06-17 2020-06-15 喘息を治療するための方法 Active JP7607939B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962862434P 2019-06-17 2019-06-17
US62/862,434 2019-06-17
PCT/US2020/037696 WO2020257093A1 (en) 2019-06-17 2020-06-15 Method for treating asthma

Publications (3)

Publication Number Publication Date
JP2022536932A JP2022536932A (ja) 2022-08-22
JP2022536932A5 JP2022536932A5 (cg-RX-API-DMAC7.html) 2023-06-22
JP7607939B2 true JP7607939B2 (ja) 2025-01-06

Family

ID=74040873

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021574818A Active JP7607939B2 (ja) 2019-06-17 2020-06-15 喘息を治療するための方法

Country Status (8)

Country Link
US (1) US20220087969A1 (cg-RX-API-DMAC7.html)
EP (1) EP3983070B1 (cg-RX-API-DMAC7.html)
JP (1) JP7607939B2 (cg-RX-API-DMAC7.html)
CN (1) CN114007690B (cg-RX-API-DMAC7.html)
AU (1) AU2020296829B2 (cg-RX-API-DMAC7.html)
CA (1) CA3141407A1 (cg-RX-API-DMAC7.html)
MX (1) MX2021015561A (cg-RX-API-DMAC7.html)
WO (1) WO2020257093A1 (cg-RX-API-DMAC7.html)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013006708A (es) * 2010-12-15 2013-09-13 Olatec Ind Llc Composicion de 3-metanosulfonilpropionitrilo para el tratamiento de la inflamacion y el dolor.
FR3046933B1 (fr) * 2016-01-25 2018-03-02 Galderma Research & Development Inhibiteurs nlrp3 pour le traitement des pathologies cutanees inflammatoires
MA44729A (fr) * 2016-04-18 2021-05-12 Novartis Ag Composés et compositions pour traiter des états associés à une activité de nlrp

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
American Journal of Respiratory and Critical Care Medicine,2017年,Vol.196, No.3,p.283-297
PNAS,2018年,Vol.115, No.7,E1530-1539
Toxicology Siences,2019年04月,Vol.170, No.2,p.462-475

Also Published As

Publication number Publication date
CN114007690B (zh) 2024-03-01
US20220087969A1 (en) 2022-03-24
CA3141407A1 (en) 2020-12-24
EP3983070B1 (en) 2024-09-11
EP3983070A1 (en) 2022-04-20
AU2020296829A1 (en) 2022-02-10
WO2020257093A1 (en) 2020-12-24
MX2021015561A (es) 2022-01-24
JP2022536932A (ja) 2022-08-22
EP3983070A4 (en) 2023-04-26
CN114007690A (zh) 2022-02-01
AU2020296829B2 (en) 2026-01-15

Similar Documents

Publication Publication Date Title
JP5196701B2 (ja) クロモリンナトリウムの経口投与用製剤
US6258816B1 (en) Anti-allergy anti-inflammatory composition
US20240245646A1 (en) Method for preventing and/or treating aging-associated cognitive impairment and neuroinflammation
RU2685706C2 (ru) Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением
SK82296A3 (en) Use of mometasone fluroate for treating airway passage and lung diseases
CN105663152A (zh) 三乙酰基-3-羟基苯基腺苷在制备改善胰岛素抵抗及相关疾病中的应用
CN114007690B (zh) 治疗哮喘的方法
CN114796183B (zh) 益母草碱在制备用于预防或治疗呼吸系统疾病的药物中的应用
CN109419787B (zh) 一种松香烷型二萜类化合物的用途
WO2024041633A1 (zh) 一种稠环嘧啶类化合物的用途
CN100394981C (zh) 一种人粒细胞巨噬细胞集落刺激因子喷雾剂及其制备方法
KR102410183B1 (ko) 이소글리시리진산 또는 이의 염의 흡입용 제제, 및 호흡 기관 질환을 치료하기 위한 약물의 제조에서의 용도
CN116712480B (zh) 一种用于预防流行性感冒的药物组合物及其制剂和应用
Jonassen et al. AP1189: A novel oral biased melanocortin agonist with anti-inflammatory and pro-resolving effect for the treatment of rheumatoid arthritis—ACR meeting abstracts
CN112023027B (zh) 胸腺素或其衍生物的应用和治疗快感缺乏型抑郁症的药物
US8722098B2 (en) Ecklonia cava extracts for alleviating or preventing asthmatic reactions
JP3428465B2 (ja) 新規な抗アレルギー抗炎症組成物
CN120000665A (zh) 雷公藤红素在制备防治ilc2细胞介导的过敏性肺部炎症药物中的应用
WO2025146212A1 (zh) N-[2-[[[4-(2,2-二甲基-1-氧代丙氧基)苯基]磺酰]氨基]苯甲酰]-(s)-甘氨酸或其盐的新用途
WO2026007876A1 (zh) Gpr84拮抗剂的用途
CN110251507A (zh) 一种针对p物质引发的哮喘的药物应用
CN118416039A (zh) 3-环丙基甲氧基-4-(二氟甲氧基)苯甲酸在制备治疗肺部疾病的药物中的应用
CN115475176A (zh) 罗汉果皂苷v在治疗溃疡性结肠炎药物中的应用
WO2022162992A1 (ja) アレルギー治療のための医薬組成物
HK1261918B (en) Method for preventing and/or treating aging-associated cognitive impairment and neuroinflammation

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230614

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230614

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240514

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240515

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240814

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241112

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241211

R150 Certificate of patent or registration of utility model

Ref document number: 7607939

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150